Controversial dwarfism drugs spur growth — but do they improve health?

Emerging treatments for achondroplasia pose difficult choices for parents. Proponents say they are changing lives. Others fear they will feed stigma and erase identity. Emerging treatments for achondroplasia pose difficult choices for parents. Proponents say they are changing lives. Others fear they will feed stigma and erase identity.

Related Keywords

Nemours ,Îe De France ,France ,Ohio ,United States ,Sonoma ,California ,Denmark ,San Rafael ,Mendoza ,Argentina ,Paris ,France General ,Tbilisi ,Georgia General ,Georgia ,Japan , ,Hellerup ,Hovedstaden ,San Diego State University ,Philadelphia ,Pennsylvania ,Palo Alto ,Delaware ,Australia ,Kyoto ,University Of Cincinnati ,Melbourne ,Victoria ,South Africa ,America ,Joseph Stramondo ,Andrea Schelhaas ,Ascendis Pharma ,Jennifer Crumly ,Liberty Anderson ,Kara Ayers ,Samantha Anderson ,Beth Rooney ,Chris Akal ,Janet Legare ,Van Rhee ,Jennifer Emerling ,Ravi Savarirayan ,Michael Hughes ,Tyra Biosciences ,Mike Anderson ,Drug Administration ,European Medicines Agency ,Researchers At Kyoto University ,University Of Cincinnati Center ,University Of Wisconsin ,Murdoch Children Research Institute ,Waisman Center ,Biotech Industry Liaison Committee ,Four Year Old Liberty Anderson ,European Medicines ,Skeletal Dysplasia Program ,Nemours Children ,Cincinnati Center ,Developmental Disabilities ,Murdoch Children ,Research Institute ,Kyoto University ,Kennett Sprog ,Little People ,Industry Liaison Committee ,